(1. 天津中医药大学中医药研究院,天津 301617;2. 天津中医药大学方剂学教育部重点实验室,天津 301617;3. 天津中医药大学中医学院,天津 301617;4. 天津中医药大学复方中药研究创新团队,天津 301617)
R277.7
收稿日期: 2019 - 12- 18
基金项目: 天津市教委科研计划项目(2018KJ007)
第一作者简介: 李霖(1990-),女,助理研究员,博士,研究方向:中医药防治心脑血管疾病。
△通信作者: 张晗,E-mail:zhanghan0023@126.com
4. Innovation Team of Research on Compound Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China)
(1.Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China;2. Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae, Tianjin University of Traditional Chinese Medicine, Ministry of Education, Tianjin 301617, China; 3. Chinese Medical College, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China;